Can magnesium supplements lower cortisol? What the evidence says

Magnesium occupies an awkward niche in the supplement market. It is marketed as a mineral, a sleep aid, a recovery tool and, more recently, as a way to lower cortisol. That last promise is what draws stressed readers in. Few are shopping for a lab value. They want quieter nights, fewer 3 a.m. wake-ups and less of the jangly feeling that gets translated into hormone language online.

The research base is more interesting than the label copy. A 2021 post-hoc analysis in Clinical Endocrinology by Joëlle C. Schutten and colleagues found that 24 weeks of 350 mg a day lowered 24-hour urinary cortisol excretion by 32 nmol/24-h versus placebo. The signal is real. It is still a long way, though, from proving that any healthy adult who buys a magnesium capsule will feel a calmer nervous system by next week.

The skeptic’s question belongs near the top: are readers hearing lower cortisol when the study actually found better sleep, less perceived stress or a small biomarker shift in a narrow subgroup? Once those outcomes are separated, magnesium looks less like a universal stress fix and more like a supplement that may help under specific conditions such as poor sleep, low magnesium status or heavy physiological stress. Nor is that skepticism fringe. A recent PBS NewsHour piece on cortisol panic made the same point from the consumer side.

Context does most of the work here. Trials in older adults with insomnia, adults with low magnesemia and athletes under training load look more promising than the fantasy version sold on social media. None of that makes the evidence weak. It makes the benefit conditional.

What the strongest trials found

The Schutten paper matters because it used an objective endpoint and gave supplementation time to work. Participants took 350 mg a day for 24 weeks, long enough to get beyond the one-bottle horizon that dominates supplement marketing. The authors wrote:

“After 24-week, urinary cortisol excretion was decreased in the magnesium group as compared with the placebo group (-32 nmol/24-h, p = .021).”

— Schutten et al., Clinical Endocrinology

Even so, it does answer an important question. Under controlled conditions, the mineral can move an objective cortisol measure. The harder question is how often that translates into a noticeable clinical benefit outside a trial.

Another useful paper came from Behnood Abbasi and colleagues in an eight-week placebo-controlled insomnia trial in older adults. Participants took 500 mg a day, and the paper reported improvements in insomnia severity alongside a drop in serum cortisol. That pairing helps explain why magnesium keeps surfacing in sleep conversations. Readers care less about the hormone in isolation than about whether they actually fall asleep faster or wake less often. Abbasi’s team reported:

“As compared to the placebo group, … resulted in significant decrease of ISI score … and serum cortisol concentration (P = 0.008).”

— Abbasi et al., Journal of Research in Medical Sciences

A third signal came from the smaller athlete study by Gordana Dmitrašinović and colleagues, which followed 23 rugby players over four weeks. It is not general-population proof. The paper still matters because training stress is one of the settings where this story makes biological sense. When recovery load is high, the nervous system is taxed and diet is inconsistent, an effect on stress markers is easier to imagine than it is in a healthy, well-rested adult who is already magnesium-replete.

Taken together, the trials support a modest claim. Magnesium can be associated with lower cortisol in some settings, especially when participants are older adults with sleep problems or athletes under stress, and when supplementation lasts longer than a few days. They do not support a broad claim that magnesium is a reliable cortisol-lowering supplement for everyone.

Why the signal is uneven

Move beyond the positive trials and the literature gets messy quickly. A 2017 systematic review in Nutrients found suggestive benefits for subjective anxiety and mild stress, but it also highlighted a problem that still hangs over the category: the studies were heterogeneous, small and not especially clean on stress measurement.

The review put it plainly:

“No study administered a validated measure of subjective stress as an outcome.”

— Boyle et al., Nutrients

That line does a better job than most supplement copy ever will. Readers are often told that magnesium supports healthy cortisol when the study actually measured sleep quality, mood or a biomarker collected under very specific conditions. Those are not interchangeable outcomes. Better sleep can coexist with no clear cortisol effect. A cortisol shift can show up without producing a dramatic change in how a person feels.

A 2021 meta-analysis on oral magnesium for insomnia in older adults lands in the same neighborhood. There may be benefit, especially around sleep onset and subjective sleep quality, but certainty is low and the trials are small. That helps explain why consumers keep hearing a confident story while the actual literature stays careful. The evidence is not empty. It is narrower and noisier than the retail pitch.

Part of the answer is probably subgroup response. The PLOS ONE trial in healthy adults with severe stress and low magnesemia found that stress scores improved in both magnesium groups, with a larger week-eight reduction in the magnesium-plus-B6 arm than in magnesium alone, 44.9% versus 42.4%. That is not a clean cortisol-only trial, but it does point toward the subgroup issue. If a participant starts with low magnesium status or obvious stress symptoms, the ceiling for improvement is higher. In a magnesium-replete adult who wants an insurance policy against modern life, the room for a detectable effect may be much smaller.

That distinction keeps the paper-first view honest. The strongest trials do not prove that magnesium is useless for people without deficiency. They do suggest that the supplement is easiest to justify when there is a plausible reason for benefit: poor sleep, low intake, gastrointestinal losses, heavy training or another setup where magnesium biology and symptom pattern line up.

What matters more than the label claim

The aisle and the evidence are not speaking the same language. A buyer sees glycinate, bisglycinate, threonate, sleep blends, stress blends and influencer shorthand about adrenal support. The trials mostly see elemental magnesium, small cohorts and endpoints that do not map neatly onto what ends up on the front of a bottle.

For shoppers, the practical question is simpler. Not whether magnesium lowers cortisol in theory, but what outcome is realistic to expect in practice. Here the evidence leans away from hormone drama and toward more ordinary endpoints. Some people may sleep a little better. Some may feel less stressed. Some may notice nothing. That is a less glamorous answer than turning down cortisol, but it is closer to what the trials actually support.

Form matters less than marketers imply, at least for cortisol. Consumer conversation in 2026 has drifted toward glycinate, bisglycinate and L-threonate, mostly because those forms are framed as gentler, calmer or better for sleep. That popularity is not the same thing as cortisol-specific proof. A recent New York Times guide to sleep supplements treated magnesium as a sleep option, not a verified cortisol hack. Older positive trials often used forms like citrate or oxide. The more defensible consumer distinction is tolerability and use case, not a claim that one trendy chelate has uniquely strong evidence for lowering stress hormones.

There is also a basic physiology problem with the way this claim gets marketed. Cortisol is not a toxin to be flushed out. It is a hormone with a normal daily rhythm, essential to waking, metabolism and adaptation. The question is not whether magnesium can crush cortisol. It is whether supplementation can improve a dysfunctional stress or sleep picture at the margins. In some studies, yes. As a blanket promise, not really.

So where does that leave the reader? Magnesium deserves a place in the conversation for sleep and stress, and there is enough trial evidence to take it seriously. But the evidence is strongest when the person has a reason to respond. Low magnesium status appears to matter. High stress load appears to matter. Sleep disturbance appears to matter. The farther a reader gets from those groups, the more the claim starts to wobble.

For clinicians and skeptical readers, the right calibration is modest rather than dismissive. Magnesium is not a fake supplement category. It is also not a cortisol master switch. The best current reading is conditional: magnesium may help some stressed or poor-sleeping adults, sometimes with a measurable cortisol change, but the effect is not consistent enough to market as a universal fix. Because dose, comorbidities and medication interactions still matter, anyone considering supplementation should consult a doctor before starting any supplement.

References

1. Schutten JC, et al. Long-term magnesium supplementation improves glucocorticoid metabolism: a post-hoc analysis of an intervention trial. Clinical Endocrinology. 2021. PubMed
2. Abbasi B, et al. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences. 2012. PMC
3. Dmitrašinović G, et al. ACTH, Cortisol and IL-6 Levels in Athletes following Magnesium Supplementation. Journal of Medical Biochemistry. 2016. PMC
4. Boyle NB, et al. The effects of magnesium supplementation on subjective anxiety and stress: a systematic review. Nutrients. 2017. PMC
5. Oral magnesium supplementation for insomnia in older adults: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies. 2021. PMC
6. Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: a randomized, single-blind clinical trial. PLOS ONE. 2018. PubMed